Embassy Office Parks REIT offers strong dividend yield, capital appreciation potential and steady rental growth in commercial ...

Eli Lilly is developing a groundbreaking drug, lepodisiran, to combat high LPA cholesterol levels prevalent in South Asians, ...

Diabetes cases could surge to 124 million by 2045, and nearly a quarter of Indian adults are already overweight or obese.

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

Eli Lilly’s Global CEO David Ricks revealed that the pharma giant might manufacture its weight-loss blockbuster, Mounjaro, in ...

Eli Lilly is exploring partnerships with Indian pharma firms to market its anti-diabetes and weight loss drug Mounjaro, ...

Unlike the US, Europe or other developed markets, Mounjaro will have to be purchased out-of-pocket in India, as obesity is ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

GCCs in life sciences and healthcare have grown across India, with Bengaluru, Hyderabad, and Chennai emerging as key hubs ...

Take a glimpse inside Indian cricketer Hardik Pandya’s lavish home in Mumbai. Situated in a prime location, the luxurious ...

Apollo 24|7’s 19-minute delivery service drives 30% of daily orders, expanding quickly across major cities with plans to ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...